Antiplatelet Therapy
CHAMPION PHOENIX: Primary Efficacy Outcomes at 48
Hours, MITT
TRITON-TIMI 3813,608 Patients With ACS and Planned PCI Randomized to Prasugrel (60/10) vs
Clopidogrel (300/75)
TRITON-TIMI 38 Bleeding Events: Safety Cohort (N = 13,457)
PLATO: Overall Mortality and CABG-Related Bleeding Rates
TiCAB Study Design
Postoperative Management
Abbreviations
Abbreviations (cont)
References
References (cont)
